全文获取类型
收费全文 | 28647篇 |
免费 | 6440篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 692篇 |
儿科学 | 931篇 |
妇产科学 | 901篇 |
基础医学 | 1517篇 |
口腔科学 | 2851篇 |
临床医学 | 4919篇 |
内科学 | 6475篇 |
皮肤病学 | 542篇 |
神经病学 | 2644篇 |
特种医学 | 1350篇 |
外科学 | 4965篇 |
综合类 | 107篇 |
现状与发展 | 12篇 |
一般理论 | 2篇 |
预防医学 | 3244篇 |
眼科学 | 431篇 |
药学 | 620篇 |
中国医学 | 31篇 |
肿瘤学 | 3011篇 |
出版年
2024年 | 136篇 |
2023年 | 1108篇 |
2022年 | 411篇 |
2021年 | 750篇 |
2020年 | 1282篇 |
2019年 | 602篇 |
2018年 | 1450篇 |
2017年 | 1375篇 |
2016年 | 1609篇 |
2015年 | 1672篇 |
2014年 | 2121篇 |
2013年 | 2608篇 |
2012年 | 1098篇 |
2011年 | 1067篇 |
2010年 | 1538篇 |
2009年 | 2114篇 |
2008年 | 1033篇 |
2007年 | 785篇 |
2006年 | 984篇 |
2005年 | 793篇 |
2004年 | 652篇 |
2003年 | 614篇 |
2002年 | 523篇 |
2001年 | 634篇 |
2000年 | 549篇 |
1999年 | 619篇 |
1998年 | 592篇 |
1997年 | 568篇 |
1996年 | 605篇 |
1995年 | 436篇 |
1994年 | 359篇 |
1993年 | 326篇 |
1992年 | 359篇 |
1991年 | 328篇 |
1990年 | 296篇 |
1989年 | 299篇 |
1988年 | 256篇 |
1987年 | 270篇 |
1986年 | 221篇 |
1985年 | 243篇 |
1984年 | 184篇 |
1983年 | 178篇 |
1982年 | 135篇 |
1981年 | 125篇 |
1979年 | 100篇 |
1978年 | 118篇 |
1977年 | 93篇 |
1975年 | 81篇 |
1974年 | 88篇 |
1972年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
4.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
5.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献
6.
7.
8.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
9.
10.